alexa Poor-quality medicines in developing countries
Pharmaceutical Sciences

Pharmaceutical Sciences

Pharmaceutical Regulatory Affairs: Open Access

Author(s): Raffaella M Ravinetto, Daniel Vandenbergh

Abstract Share this page

We welcome the attention given to the serious public-health problem represented by the spread of poor-quality medicines in developing countries, and we would like to comment on some points expressed in the recent Newsdesk feature by Kathryn Senior1 on the global health-care implications of substandard medicines.

This article was published in Lancet Infectious Diseases and referenced in Pharmaceutical Regulatory Affairs: Open Access

Relevant Expert PPTs

Relevant Speaker PPTs

Recommended Conferences

Relevant Topics

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords